BioSpace News Archive

Biophytis SA announced that it has signed a master service agreement with the pharmaceutical company Intsel Chimos, which will become its Pharmaceutical Operator/Exploitant in France for Sarconeos in the context of the early access program application, requested for the treatment of severe forms of COVID-19, if approved.

MorphoSys AG announces that it will stop work and operations on its pre-clinical research programs to optimize its cost structure.

Cosette Pharmaceuticals Launches Betaine Anhydrous Powder, AB-rated to Cystadane ® (betaine anhydrous for oral solution).

Tarsus Pharmaceuticals, Inc., whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, announced that management will participate at the following conferences.